World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
68
Citations
24838
World Ranking
2546
National Ranking
1220

Robert F. Garry publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Robert F. Garry sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 343 publications — 72nd percentile

72% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Robert F. Garry D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Robert F. Garry sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 68 D-Index — 49th percentile

49% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Robert F. Garry is affiliated with Tulane University in the United States and has contributed extensively to the field of medicine, focusing primarily on infectious diseases. Their research encompasses various subfields including Infectious Diseases, Epidemiology, Emergency Medical Services, Molecular Biology, and Modeling and Simulation.

Among the main topics of their work are:

  • Viral Infections and Outbreaks Research
  • SARS-CoV-2 and COVID-19 Research
  • Viral Infections and Vectors
  • Disaster Response and Management
  • Hepatitis B Virus Studies
  • COVID-19 Epidemiological Studies
  • Viral Gastroenteritis Research and Epidemiology

Some of the recent papers associated with Robert F. Garry include:

  • The proximal origin of SARS-CoV-2, 2020, Nature Medicine
  • The origins of SARS-CoV-2: A critical review, 2021, Cell
  • After the pandemic: perspectives on the future trajectory of COVID-19, 2021, Nature
  • The Huanan Seafood Wholesale Market in Wuhan was the early epicenter of the COVID-19 pandemic, 2022, Science
  • Persistence of Severe Acute Respiratory Syndrome Coronavirus 2 in Aerosol Suspensions, 2020, Emerging Infectious Diseases

Frequent co-authors in their research collaborations include:

  • Kristian G. Andersen
  • Donald S. Grant
  • John S. Schieffelin
  • Mambu Momoh
  • Luis M. Branco

Robert F. Garry has published extensively in a variety of scientific venues. Frequent publication outlets include:

  • bioRxiv (Cold Spring Harbor Laboratory)
  • Viruses
  • Zenodo (CERN European Organization for Nuclear Research)
  • Journal of Virology
  • PLoS Neglected Tropical Diseases

In addition to journal publications, Robert F. Garry contributed to book literature, including a work published by Springer Science+Business Media titled Lassa Fever: Epidemiology, Immunology, Diagnostics, and Therapeutics in 2023.

Best Publications

  • Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)

    Daniel J. Klionsky;Amal Kamal Abdel-Aziz;Sara Abdelfatah;Mahmoud Abdellatif

  • The proximal origin of SARS-CoV-2.

    Kristian G. Andersen;Kristian G. Andersen;Andrew Rambaut;W. Ian Lipkin;Edward C. Holmes

  • Genomic surveillance elucidates Ebola virus origin and transmission during the 2014 outbreak

    Stephen K. Gire;Stephen K. Gire;Augustine Goba;Kristian G. Andersen;Kristian G. Andersen;Rachel S G Sealfon;Rachel S G Sealfon

  • Clinical Illness and Outcomes in Patients with Ebola in Sierra Leone

    J. S. Schieffelin;A. Goba;M. Gbakie;A. Colubri

  • A General Model for the Transmembrane Proteins of HIV and Other Retroviruses

    William R. Gallaher;Judith M. Ball;Robert F. Garry;Mark C. Griffin

  • The Origins of SARS-CoV-2: A Critical Review

    Edward C. Holmes;Stephen A. Goldstein;Angela L. Rasmussen;David L. Robertson

  • Virus genomes reveal factors that spread and sustained the Ebola epidemic

    Gytis Dudas;Gytis Dudas;Luiz Max Carvalho;Trevor Bedford;Andrew J. Tatem

  • After the pandemic: perspectives on the future trajectory of COVID-19.

    Amalio Telenti;Ann Arvin;Lawrence Corey;Davide Corti

  • Genomic epidemiology reveals multiple introductions of Zika virus into the United States.

    Nathan D. Grubaugh;Jason T. Ladner;Moritz U. G. Kraemer;Moritz U. G. Kraemer;Gytis Dudas

  • Persistence of Severe Acute Respiratory Syndrome Coronavirus 2 in Aerosol Suspensions.

    Alyssa C. Fears;William B. Klimstra;Paul Duprex;Amy Hartman

  • Ebola virus epidemiology, transmission, and evolution during seven months in Sierra Leone

    Daniel J. Park;Gytis Dudas;Shirlee Wohl;Shirlee Wohl;Augustine Goba

  • The molecular epidemiology of multiple zoonotic origins of SARS-CoV-2

    Unknown

  • Clinical Sequencing Uncovers Origins and Evolution of Lassa Virus

    Kristian G. Andersen;Kristian G. Andersen;Kristian G. Andersen;B. Jesse Shapiro;B. Jesse Shapiro;B. Jesse Shapiro;Christian B. Matranga;Rachel Sealfon;Rachel Sealfon

  • Structural basis for antibody-mediated neutralization of Lassa virus

    Kathryn M. Hastie;Michelle A. Zandonatti;Lara M. Kleinfelter;Megan L. Heinrich

  • Lassa Fever in Post-Conflict Sierra Leone

    Jeffrey G. Shaffer;Donald S. Grant;John S. Schieffelin;Matt L. Boisen

  • Detection of a human intracisternal A-type retroviral particle antigenically related to HIV

    Robert F. Garry;Cesar D. Fermin;Darrenn J. Hart;Steven S. Alexander

  • Detection of serum antibodies to retroviral proteins in patients with primary sjögren's syndrome (autoimmune exocrinopathy)

    Norman Talal;Michael J. Dauphinée;Michael J. Dauphinée;Howard Dang;Steve S. Alexander

  • Peptide inhibitors of dengue virus and West Nile virus infectivity

    Yancey M Hrobowski;Robert F Garry;Scott F Michael

  • New opportunities for field research on the pathogenesis and treatment of Lassa fever.

    Sheik Humarr Khan;Augustine Goba;May Chu;Cathy Roth

  • Interferon-beta and interferon-gamma synergistically inhibit the replication of severe acute respiratory syndrome-associated coronavirus (SARS-CoV).

    Bruno Sainz;Eric C. Mossel;C.J. Peters;Robert F. Garry

  • Genomic Analysis of Lassa Virus during an Increase in Cases in Nigeria in 2018.

    Katherine J. Siddle;Philomena Eromon;Kayla G. Barnes;Samar Mehta

  • Detection of retroviral antibodies in primary biliary cirrhosis and other idiopathic biliary disorders

    Andrew L. Mason;Lizhe Xu;Linsheng Guo;Santiago Munoz

  • A conserved idiotype and antibodies to retroviral proteins in systemic lupus erythematosus.

    Norman Talal;Robert F. Garry;Peter H. Schur;Steve Alexander

Frequent Co-Authors

Pardis C. Sabeti
Pardis C. Sabeti Harvard University
Kristian G. Andersen
Kristian G. Andersen Scripps Research Institute
Stephen F. Schaffner
Stephen F. Schaffner Broad Institute
Erica Ollmann Saphire
Erica Ollmann Saphire La Jolla Institute For Allergy & Immunology
William C. Wimley
William C. Wimley Tulane University
Thomas W. Geisbert
Thomas W. Geisbert The University of Texas Medical Branch at Galveston
Gustavo Palacios
Gustavo Palacios Icahn School of Medicine at Mount Sinai
Andrew Rambaut
Andrew Rambaut University of Edinburgh
Andreas Gnirke
Andreas Gnirke Broad Institute
Joan B. Geisbert
Joan B. Geisbert The University of Texas Medical Branch at Galveston

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students interested in Immunology, expanding education in related healthcare fields can open diverse career opportunities. Many professionals pursue advanced nursing degrees, such as the affordable pmhnp programs, which specialize in psychiatric mental health and intersect with immunological conditions through behavioral health.

Choosing a specialty with high earning potential is another key concern. The highest paid dnp specialties provide useful guidance on how different nurse practitioner roles compare in terms of salary, helping guide education and career planning towards financial sustainability.

For nurse practitioners wanting to broaden or shift their clinical focus, obtaining an acute care np certification can be a strategic move. This certification enables practitioners to work with patients in critical and complex care settings, which often involve immunological challenges.

Students seeking to accelerate their entry into nursing leadership and practice can consider a nurse practitioner accelerated program. These programs speed up the pathway to advanced practice roles, complementing foundational knowledge in immunology with clinical expertise.

Best Scientists Citing Robert F. Garry

Trending Scientists

Recently Published Articles